Evidence map›Paper›PMID 34530800›Full record

ArticleBMC public health2021

Impact of a health literacy intervention combining general practitioner training and a consumer facing intervention to improve colorectal cancer screening in underserved areas: protocol for a multicentric cluster randomized controlled trial.

Marie-Anne Durand, Aurore Lamouroux, Niamh M Redmond, Michel Rotily, Aurélie Bourmaud, Anne-Marie Schott, Isabelle Auger-Aubin, Adèle Frachon, Catherine Exbrayat, Christian Balamou and 12 more

Open access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMC public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Racial and sociodemographic distribution of colorectal cancer screening in Canada: A cross-sectional study.Canadian journal of public health = Revue canadienne de sante publique · 2024
    Article
  10. Observational
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 10 institutions in 3 countries.

Marie-Anne DurandCERPOP, INSERM UMR1295, Université Toulouse III Paul Sabatier, Inserm, UPS, Toulouse, France.
Aurore LamourouxAssistance Publique - Hôpitaux de Marseille, Marseille, France.
Niamh M RedmondCERPOP, INSERM UMR1295, Université Toulouse III Paul Sabatier, Inserm, UPS, Toulouse, France. niamh-maria.redmond@univ-tlse3.fr.ORCID 0000-0001-8814-3396
Michel RotilyAssistance Publique - Hôpitaux de Marseille, Marseille, France.
Aurélie BourmaudINSERM, UMR-S 1123 ECEVE Université de Paris, Paris, France.
Anne-Marie SchottINSERM, UMR 1290 RESHAPE Université Lyon 1, Lyon, France.
Isabelle Auger-AubinDépartement de Médecine Générale, Université de Paris, Paris, France.
Adèle FrachonDépartement de Médecine Générale, Université de Paris, Paris, France.
Catherine ExbrayatCentre Régional de Coordination du Dépistage des Cancers (CRCDC-AuRA), Auvergne-Rhônes-Alpes, Saint Étienne, Cedex 02, France.
Christian BalamouCentre Régional de Coordination du Dépistage des Cancers (CRCDC-AuRA), Auvergne-Rhônes-Alpes, Saint Étienne, Cedex 02, France.
Laëtitia GimenezCERPOP, INSERM UMR1295, Université Toulouse III Paul Sabatier, Inserm, UPS, Toulouse, France.
Pascale GrosclaudeCERPOP, INSERM UMR1295, Université Toulouse III Paul Sabatier, Inserm, UPS, Toulouse, France.
Nora MoumjidP2S EA4129, Centre Léon Bérard, Université Lyon 1, Lyon, France.
Julie HaesebaertINSERM, UMR 1290 RESHAPE Université Lyon 1, Lyon, France.
Helene Delattre MassyCentre Régional de Coordination du Dépistage des Cancers d'Ile de France (CRCDC-IDF), Paris, France.
Julia BardesCentre Régional de Coordination du Dépistage des Cancers d'Ile de France (CRCDC-IDF), Paris, France.
Rajae TouzaniInstitut Paoli Calmettes, SESSTIM UMR1252, Marseille, France.
Laury Beaubrun En Famille DiantLaboratoire CERPPS, EA 7411, Université Toulouse II Jean Jaurès, Toulouse, France.
Clémence CasanovaAix-Marseille Université, APHM, INSERM, IRD, SESSTIM, "Cancer, Biomedicine & Society" group, Hôpital Timone, Marseille, France.
Jean François SeitzService d'Hépato-Gastroentérologie, Hôpital Timone, Assistance Publique Hôpitaux Marseille & Aix-Marseille-Université, Marseille, France.
Julien ManciniAix-Marseille Université, APHM, INSERM, IRD, SESSTIM, "Cancer, Biomedicine & Society" group, Hôpital Timone, Marseille, France.
Cyrille DelpierreCERPOP, INSERM UMR1295, Université Toulouse III Paul Sabatier, Inserm, UPS, Toulouse, France.
Inserm · FRUniversité Toulouse III - Paul Sabatier · FRUniversité Claude Bernard Lyon 1 · FRCentre Val de Loire · FRUniversité Paris Cité · FRAix-Marseille Université · FRCeres · USDartmouth College · USUniversité d'Avignon et des Pays de Vaucluse · FRUniversité Toulouse - Jean Jaurès · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundColorectal cancer (CRC) is a leading cause of cancer burden worldwide. In France, it is the second most common cause of cancer death after lung cancer. Systematic uptake of CRC screening can improve survival rates. However, people with limited health literacy (HL) and lower socioeconomic position rarely participate. Our aim is to assess the impact of an intervention combining HL and CRC screening training for general practitioners (GPs) with a pictorial brochure and video targeting eligible patients, to increase CRC screening and other secondary outcomes, after 1 year, in several underserved geographic areas in France.

methodsWe will use a two-arm multicentric randomized controlled cluster trial with 32 GPs primarily serving underserved populations across four regions in France with 1024 patients recruited. GPs practicing in underserved areas (identified using the European Deprivation Index) will be block-randomized to: 1) a combined intervention (HL and CRC training + brochure and video for eligible patients), or 2) usual care. Patients will be included if they are between 50 and 74 years old, eligible for CRC screening, and present to recruited GPs. The primary outcome is CRC screening uptake after 1 year. Secondary outcomes include increasing knowledge and patient activation. After trial recruitment, we will conduct semi-structured interviews with up to 24 GPs (up to 8 in each region) and up to 48 patients (6 to 12 per region) based on data saturation. We will explore strategies that promote the intervention's sustained use and rapid implementation using Normalization Process Theory. We will follow a community-based participatory research approach throughout the trial. For the analyses, we will adopt a regression framework for all quantitative data. We will also use exploratory mediation analyses. We will analyze all qualitative data using a framework analysis guided by Normalization Process Theory. DISCUSSION: Limited HL and its impact on the general population is a growing public health and policy challenge worldwide. It has received limited attention in France. A combined HL intervention could reduce disparities in CRC screening, increase screening rates among the most vulnerable populations, and increase knowledge and activation (beneficial in the context of repeated screening).

trial registrationRegistry: ClinicalTrials.gov. TRIAL REGISTRATION NUMBER: 2020-A01687-32 . Date of registration: 17th November 2020.

Indexed as

Colorectal NeoplasmsGeneral PractitionersHealth LiteracyAgedEarly Detection of CancerHumansMedically Underserved AreaMiddle AgedMulticenter Studies as TopicRandomized Controlled Trials as TopicColorectal cancer screeningGeneral practitioner training, health disparitiesHealth literacyIntervention

Identifiers

PMID34530800
PMCPMC8444501
OpenAlexW3199125772

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.